ReBio
Through The Lens of Progress
Finland
22 employees
Grant
Total: $5.41M
Biotechnology, Health Care +1
General Information
Finland
BounceWatch is an independent company data service, not affiliated with ReBio. To contact ReBio, visit rebiopharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ReBio compare?
A PDF of ReBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ReBio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Finland Market
Biotechnology
About ReBio
Business keywords: Biotech, Ophthalmology, Drug Delivery, Sustained Release Technology, Chronic Eye Disorders, SiSu® Technology, Innovation, Medical Franchise, Surrey, United Kingdom, Start-up, Biomedical Research
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €410.00K | 1 |
|
07 Jan 2020 |
| Seed Round | $2.00M | 2 |
|
13 Nov 2018 |
| Seed Round | $3.00M | 1 |
|
27 Nov 2014 |
ReBio Alternatives & Competitors
View All Alternatives
Revolutionizing Patient Care via "Cozy-Cure": Better Treatments, Enhanced Patient Lives
LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®
FAQ About ReBio
Source: BounceWatch company record for ReBio, https://bouncewatch.com/company/rebio-technologies, updated 29 December 2024. When citing, please name BounceWatch and link this page.
